Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918136 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Adipose-Derived Stem Cell Injection Partial Thickness Rotator Cuff Tears
A NA study, sponsored by InGeneron.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02918136 is a NA study that has completed, run by InGeneron. The registered enrollment target is 18 participants.
The verdict
NCT02918136, a NA study, has completed, sponsored by InGeneron.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a prospective, randomized, multi-site, safety and efficacy study in subjects with rotator cuff injuries. Patients will fall into two categories: treatment group (12 subjects) and non-treatment or control group (six subjects). The treatment group will undergo a small liposuction procedure and receive rotator cuff repair treatment with an ultrasound-guided injection of 5cc adipose-derived stem cells (ADSCs) into the point of injury. The control group will receive a 5cc cortisone injection into the point of injury
Interventions
- BIOLOGICAL Adipose derived regenerative cells
- DRUG Cortisone Injectable
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02918136
The ClinicalTrials.gov registry entry for NCT02918136 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InGeneron, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adipose derived regenerative cells is the first listed.
NCT02918136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02918136 about?
NCT02918136 is a clinical study titled "Safety and Efficacy Adipose-Derived Stem Cell Injection Partial Thickness Rotator Cuff Tears". This is a prospective, randomized, multi-site, safety and efficacy study in subjects with rotator cuff injuries. Patients will fall into two categories: treatment group (12 subjects) and non-treatment or control group (six subjects). The treatment group will undergo a small liposuction procedure an...
What is the current status of trial NCT02918136?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2016-12. Estimated completion is 2018-12-13.
What interventions are being tested in trial NCT02918136?
The interventions under investigation include: Adipose derived regenerative cells (BIOLOGICAL), Cortisone Injectable (DRUG).
Who is sponsoring clinical trial NCT02918136?
This trial is sponsored by InGeneron, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.